Pfizer, every mention
12 scenes · ← back to Pfizer
tap a year for its mentions
every year anyone Andy Acker 4Steve Galbraith 2Rodrigo Bitar 1Rick Heitzman 1Mitchell Green 1Mike Vieth 1Jan Garfinkel 1Isaac Corre 1Clark Futch 1
Verbatim, from the transcripts: the passages where Pfizer comes up
Rodrigo Bitar – Overlooked Opportunities in Latin America (EP.442)
- ▶ 21:23 Rodrigo Bitar And then we subsequently acquired the assets of Pfizer in Venezuela.
Mitchell Green - Lead Edge of Harnessing Networks (EP.429)
- ▶ 30:52 Mitchell Green Would you want to meet the former CEO of Pfizer?
Chad Summe and Mike Veith – Corridor of Commerce at eGateway Capital (EP.364)
- ▶ 34:08 Mike Vieth So Apple, Dell, Microsoft, Pfizer, Bristol-Myers, some cold storage, where they're
Rick Heitzmann – New York Venture Investing at FirstMark Capital (EP.350)
- ▶ 26:21 Rick Heitzman And a lot of folks who are here, and whether they work for CVS, Pfizer, large health system, are still getting to know people, but are interested in what does digital health mean for providers or for payers?
Isaac Corre – Event-Driven Investing at Governors Lane (EP.344)
- ▶ 20:58 Isaac Corre This was true in 2009 when Pfizer was buying Wyeth and Merck was buying Shearing Plow.
Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)
- ▶ 31:37 Andy Acker And then Pfizer came along and decided they wanted to buy the company. 2 times in the scene
- ▶ 39:11 Andy Acker And as an example, you know, BioNTech, which is the company that made the first MRNA vaccine along with Pfizer, we invest in that company when it was still a private company back in 2017 when most people had never heard of MRNA.
- ▶ 47:40 Andy Acker And even just Pfizer alone has said that they need to make acquisitions to acquire twenty five billion dollars of revenue by the end of 2030.
Jan Garfinkle – Arboretum Ventures (Manager Meetings, EP.09)
- ▶ 50:22 Jan Garfinkel We then brought in Series B, which was Baird and Pfizer, and continued to develop the product.
Clarke Futch – Healthcare Royalty Partners (First Meeting, EP.20)
- ▶ 11:56 Clark Futch The big companies, the GlaxoSmithKline's, Merck, Pfizer's of the world, they would invent 60, 70% of their products internally in their own research and development laboratories.
Steven Galbraith – In the Boardroom (Capital Allocators, EP.48)
- ▶ 32:03 Steve Galbraith So at Tufts, we had a bunch of, you know, CEO of Pfizer, Bristol, DuPont, and a bunch of Wall Street clowns like myself.
Steven Galbraith – Five Tool Player (Capital Allocators, EP.01)
- ▶ 1:12:04 Steve Galbraith Like, at Tufts, we have CEOs of a couple of large, you know, Pfizer, Bristol Myers, DuPont.